Drospirenone/E2 reduces BP in postmenopausal women with hypertension

Article

Hormonal therapy with drospirenone plus estradiol (E?) lowers blood pressure and spares potassium in postmenopausal women on hydrochlorothiazide (HCTZ). So say results of a small randomized, placebo-controlled trial presented at the 17th annual NAMS meeting.

Hormonal therapy with drospirenone plus estradiol (E2) lowers blood pressure and spares potassium in postmenopausal women on hydrochlorothiazide (HCTZ). So say results of a small randomized, placebo-controlled trial presented at the 17th annual NAMS meeting.

Thirty-six women taking 25 mg/d of HCTZ for stage 1 hypertension were included in the crossover study, conducted by investigators from the University of Miami and Berlex Laboratories. The participants were randomized to 3 mg drospirenone/E2 or placebo for 4 weeks and then crossed over for another 4 weeks.

Drospirenone/E2 reduced systolic and diastolic blood pressure by 7.2 mm Hg and 4.5 mm Hg, respectively, and potassium was 0.2 mEq/L higher than with placebo. The only significant adverse effects of the hormonal therapy were vaginal bleeding and breast tenderness.

Recent Videos
Devon Ramaeker, MD
Elizabeth Gandee, APRN-CNP, highlights gaps in women's menopause knowledge | Image Credit: wexnermedical.osu.edu
Doula highlights how postpartum care is failing new mothers | Image Credit: linkedin.com
Nicky Herrick MD; and Anushree Agarwal, MD, MBBS, highlight their study on cardiac arrhythmias in pregnancy | Image Credit: © Igor Borodin - stock.adobe.com.
Lisa Becht, MD, FACOG, sheds light on fertility awareness | Image Credit: havingbabies.com.
First US national HPV conference highlights advances in cancer prevention | Image Credit: uchealth.com.
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
Shayna Mancuso, DO, highlights the real impact of menopause | Image Credit: linkedin.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.